Cigna Group
XMUN:CGN
Cigna Group
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients.
Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients.
Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
Revenue Growth: Cigna delivered full year 2025 adjusted revenue of $275 billion, up 11% year-over-year, driven by specialty pharmacy strength and client relationships.
EPS Performance: Adjusted earnings per share reached $29.84 in 2025, a 9% increase; management reaffirmed confidence in at least $30.25 EPS for 2026.
FTC Settlement & PBM Reform: The global FTC settlement and recent PBM legislation provide regulatory clarity; Cigna expects the margin profile and long-term growth for its pharmacy benefit business to remain intact.
Specialty & Care Momentum: Specialty and Care Services achieved 14% revenue growth and now contribute about 35% of overall company income.
Cash Flow & Capital Return: Operating cash flow was strong at $9.6 billion in 2025; Cigna returned $5.2 billion to shareholders via buybacks and dividends.
2026 Guidance: Management projects $280 billion in adjusted revenue and at least $30.25 EPS, with stable SG&A ratio and medical care ratio guidance reflecting cost pressures and pricing actions.
PBM Model Transition: Cigna's new rebate-free pharmacy benefit model will be the standard offering by 2028, with at least 50% of Evernorth clients expected to adopt by then; no significant revenue recognition changes expected.
